1. What are the direct medical costs of managing Type 2 Diabetes Mellitus in Malaysia?
  2. Pharmaceutical Association of Malaysia (PhAMA) - MIMS Search Database
  3. Latest MIMS news
  4. MIMS Pharmacy Malaysia 2016/2017 is now available

Essential Clinical Practice Toolkit On-The-Go! The FREE MIMS app for iPhone, iPod Touch & iPad delivers critical prescribing information, medical news and. Get access to disease management charts, dosage guidelines and much more. Content includes: • MIMS Pharmacy Malaysia / includes: Disease. Search by Drug Name, Indications, Dosage in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia, India & USA.

Language:English, Spanish, French
Genre:Health & Fitness
Published (Last):29.04.2016
Distribution:Free* [*Sign up for free]
Uploaded by: DEANDRA

73152 downloads 89895 Views 28.85MB PDF Size Report

Mims Malaysia Pdf

The additional charges apply to orders from East Malaysia. For Tax Exemption purposes, Official Receipt is available upon request. For Bulk Order Discount. The Choice Mobile Resource for Medical Professionals. MIMS Mobile app app delivers critical prescribing information, medical news and CME articles even. Search drug, interactions and image information in China, Hong Kong, Taiwan, Malaysia, S'pore, Philippines, Vietnam, Thailand, Indonesia, India & USA.

Sotagliflozin affords cardiorenal protection in type 1 diabetes Jairia Dela Cruz, 20 Jun Dual sodium-glucose linked transporter 1 and 2 inhibition with sotagliflozin confers cardiorenal protective benefits in patients with type 1 diabetes, with the drug inducing blood pressure reductions, albuminuria declines and estimated glomerular filtration rate changes, according to a study presented at the 79th Scientific Sessions of the American Diabetes Association ADA The CV benefits come with potential renal benefits, with the largest effect seen for macroalbuminuria in an exploratory analysis. Total healthcare costs just about the same between empagliflozin and DPP-4 inhibitors Jairia Dela Cruz, 19 Jun Type 2 diabetes mellitus patients treated with either the sodium-glucose cotransporter-2 inhibitor empagliflozin or dipeptidyl peptidase 4 inhibitors incur similar overall healthcare costs, according to data from the EMPRISE trial presented at the 79th Scientific Sessions of the American Diabetes Association ADA

PI had adequate pediatric dosing information. Pediatric drug important implications on policy and clearly suggests a closer labeling: Improving the safety and efficacy of pediatric therapies.

JAMA ; — Changes in availability of paediatric peutically neglected population. Drug regulatory authorities in medicines in Australia between and Phar- Malaysia and other countries need to introduce an obligatory macol.

What are the direct medical costs of managing Type 2 Diabetes Mellitus in Malaysia?

Pharmacokinetic and pharmacodynamic data use in children to have pediatric dosing information and to be collection in children and neonates. Therapeutic orphans [editorial]. Dosing informa- — Optimizing pediatric dosing: A develop- Med. Media Medica, Selangor, Medicines for children—the last century and the 14 Law of Malaysia, Act Poison Act Paediatric drug studies. Protecting pint-sized 4 Shirkey HC.

Therapeutic orphans: Who speaks for children? FDA Consum.

Pediatric prescribing: Using unlicensed drugs and 5 Wilson JT. Pragmatic assessment of medicines available for young medicines outside their licensed indication.

In: Morselli ; 5—8. Children, drugs, and the food and drug administration: Perinatal Pharmacology. Raven Press, New York, ; — Repeated infusions of ketamine provide antidepressant effects, with reductions in depressive symptoms sustained through once-weekly infusions among responders, suggests a study.

Acetaminophen safe for seniors in nursing homes. Acetaminophen remains a safe choice of analgesic for most elderly residents of nursing homes, a recent study suggests. HSA issues recall for tainted losartan products.

Jairia Dela Cruz, 2 days ago. Three brands of the blood pressure-lowering drug losartan in Singapore have been recalled by the Health Sciences Authority HSA for containing trace amounts of nitrosamine impurity, which may contribute to an increased cancer risk. Corticosteroid use inconsistent in patients receiving checkpoint inhibitors.

There appears to be a highly variable use of steroid for the management of immune-related adverse effect, according to a study, with most patients receiving prolonged courses of steroids and resuming checkpoint inhibitor therapy with concomitant steroids above recommended doses.

Higher initial romiplostim doses cut time to platelet response in immune thrombocytopaenia. It appears that higher initial doses of romiplostim is safe for hospitalized patients with treatment-refractory immune thrombocytopaenia, reports a study. Higher initial doses, compared to dosing approved by the Food and Drug Administration, may shorten time to platelet responses and hospital length of stay.

Pharmaceutical Association of Malaysia (PhAMA) - MIMS Search Database

Product Highlight - Forxiga. Dapagliflozin 5 mg and 10 mg FC tab. Comprehensive genomic profiling in oncology — from vision to reality.

Jeffrey Ross, Dr. Rohit Lal, Prof. Rebecca Dent, Prof.

Latest MIMS news

Rafal Dziadziuszko, 24 Jan Comprehensive genomic profiling CGP has emerged as a key driving force behind personalized cancer care. With the wealth of data available with CGP, medical oncologists now have in their armamentarium a tool that could enable them to provide patients with the optimum treatment.

Real-world management of stable coronary artery disease.

Different standards of medicines information provided in these three countries suggest that pharmaceutical promotion needs to be better controlled at the international level. Keywords: Pharmaceutical advertisements, promotion, regulation, Malaysia, Australia Introduction Journal advertising is used by pharmaceutical companies as a marketing strategy to promote pharmaceutical products to health professionals. The Ethical Criteria for Medicinal Drug Promotion was established to support and encourage the improvement of health care through the rational use of medicinal drugs [ 7 ].

You might also like: DA PDF A WORD FREE ITALIANO

It sets out the general standards for ethical promotion of pharmaceutical products that can be used as a model bygovernments [ 7 ]. Contrary to the WHO Ethical Criteria, the IFPMA code does not require information on warnings, major interactions, and content of active ingredient per dosage form or regimen and name of other ingredients known to cause problems to be provided in advertisements.

MIMS Pharmacy Malaysia 2016/2017 is now available

The IFPMA code requires that all promotional material should be consistent with locally approved product information [ 8 ]. The US is a country with a long-established control system by governmental agencies [ 9 ]. Australia [ 11 ] and Malaysia [ 12 ] are examples of developed and emerging countries, respectively, where pharmaceutical companies self-regulate their promotional activities by implementing voluntary codes of conduct which complement the requirements set by government legislation.

The codes, regulations and legislation provide standards for all types of promotional materials for prescription medicines including all printed and audiovisual promotional materials. In Australia, pharmaceutical advertising is regulated by government legislation through the Therapeutic Goods Act [ 13 ]. Medicines Australia, which represents research-based pharmaceutical companies, administers a code of conduct for promotional practice [ 11 ].

Similarly, in Malaysia pharmaceutical advertising for prescription medicines is regulated by government legislation through the Medicine Advertisement and Sale Act [ 14 ].

The Pharmaceutical Association of Malaysia PhAMA , which represents pharmaceutical companies, administers a code of conduct as a guide for the advertising of prescription medicines [ 12 ].

Failure to comply with the codes will result in sanctions including discontinuation or modification of any practice that is determined to breach the code, the issuance of retraction statements, fines, suspension or expulsion from Medicines Australia or the PhAMA [ 11 , 12 ]. FDA may issue regulatory letters to any pharmaceutical company that is found to be in breach of the laws.

The letters may serve as a basis for additional regulatory action including recalls or seizures of promotional materials or activities, and criminal prosecution [ 16 ]. Most pharmaceutical companies are international companies.

Generally, every pharmaceutical company has their own set of ethical standards based on the standards set forth in the IFPMA code of conduct. According to the codes that are publicly available [ 17 - 19 ], promotional materials should support the appropriate use of medicines by presenting information accurately, without exaggeration and must follow all relevant local laws and company policies and procedures. Despite the existence of regulations and control of medicine promotion, the quality of medicines information in journal advertising has been questioned.

A systematic review [ 20 ] identified nine studies that evaluated provision of medicines information.

Related articles:

Copyright © 2019 All rights reserved.